Nucleic acid molecules that inhibit the expression of TSLP

TW202633660APending Publication Date: 2026-08-16MOCHIDA PHARM CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114142169
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-09-29
Filing Date: 2025-10-30
Publication Date: 2026-08-16

Application Information

Patent Timeline

29 Sep 2025

Priority

30 Oct 2025

Application

TW114142169

16 Aug 2026

Publication

TW202633660A

IPC: A61K31/7088; A61P11/00; C12N15/113

Inventors: 神野泰𨺓; 永末央

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

This invention relates to nucleic acid molecules that can inhibit the expression of thymic stromal lymphopoietin (TSLP) or genes encoding TSLP, their salts, solvates, pharmaceutical compositions characterized by containing these as active ingredients, and preventive and / or therapeutic agents for diseases presumed to be related to TSLP.

Need to check novelty before this filing date? Find Prior Art